Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Initiation and discontinuation of complementary therapy among cancer patients.

Initiation and discontinuation of complementary therapy among cancer patients. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Initiation and discontinuation of complementary therapy among cancer patients. Abstract Text:

    sung-gyeong kimSung-Gyeong Kim,eun-cheol parkEun-Cheol Park,jae-hyun parkJae-Hyun Park,myung-il hahmMyung-Il Hahm,jin-hwa limJin-Hwa Lim,kui-son choiKui-Son Choi,sung-gyeong kimSung-Gyeong Kim,eun-cheol parkEun-Cheol Park,jae-hyun parkJae-Hyun Park,myung-il hahmMyung-Il Hahm,jin-hwa limJin-Hwa Lim,kui-son choiKui-Son Choi,

    PURPOSE: To identify the initiation or discontinuation of complementary therapy (CT) and determine the impact of sociodemographic and clinical factors on CT use among cancer patients. PATIENTS AND METHODS: Eligible patients were age 20 or older; newly diagnosed with stomach, liver, or colorectal cancer; and started their initial treatment at the National Cancer Center, Korea, between April 1, 2001, and April 30, 2003. In total, 541 cancer patients were surveyed in face-to-face interviews at baseline, and telephone follow-up interviews were performed every 3 months for 3 years. RESULTS: A total of 281 patients commenced CT after diagnosis; 164 patients stopped using CT during the follow-up period. The overall cumulative probability of starting CT at 1, 2, and 3 years was 50%, 54%, and 55%, respectively. In a Cox multivariate analysis, stomach and liver cancer were associated with an increased probability of initiating CT compared with colorectal cancer. Patients who were classified as stage I, II, or III at diagnosis were associated with a decreased probability of discontinuing CT compared with stage IV. CONCLUSION: Most cancer patients started to use CT during the initial treatment period. Thus, physicians should communicate with cancer patients about CT at this phase. In particular, more attention should be paid to women and individuals with higher household incomes because these groups are more likely to start CT.

    Initiation and discontinuation of complementary therapy among cancer patients. Publishing Authors By Initials

    sg kimSG Kim,ec parkEC Park,jh parkJH Park,mi hahmMI Hahm,jh limJH Lim,ks choiKS Choi,sg kimSG Kim,ec parkEC Park,jh parkJH Park,mi hahmMI Hahm,jh limJH Lim,ks choiKS Choi,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Initiation and discontinuation of complementary therapy among cancer patients. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Journal of clinical oncology : official journal of

    VOLUME: 25

    Page Numbers: 5267-74

    Journal Abbreviation: J. Clin. Oncol.

    ISSN: 1527-7755

    DAY: 20

    MONTH: Nov

    YEAR: 2007

    Initiation and discontinuation of complementary therapy among cancer patients. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8309333

    Initiation and discontinuation of complementary therapy among cancer patients. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Initiation and discontinuation of complementary therapy among cancer patients. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Initiation and discontinuation of complementary therapy among cancer patients.

    AFFILIATION: Division of Cancer Policy and Management, National Cancer Control Research Institute, National Cancer Center, 809 Madu 1-dong, Il sandong-gu, Goyang-si, Gyeonggi-do 410-769, Korea.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Clin Oncol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Initiation and discontinuation of complementary therapy among cancer patients Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News